Enalaprilat
Note: This product is not licenced in Australia at the time of publication. The information in this monograph applies to the specified brand, formulation and strength only.
Trade name
Enalaprilat USP (West-Ward Pharmaceuticals Corp)
Strength
1.25 mg/mL (volume: 1 mL, 2 mL)
IV administration
Use undiluted or dilute to 25 microgram/mL or weaker and give over at least 5 minutes.
Haemodialysis or risk of excessive hypotension: Infuse over 1 hour.
Other routes of administration
IM: Not recommended.
SC: Not recommended.
Compatible IV fluids
Glucose 5%
Glucose 5% and sodium chloride 0.9%
Sodium chloride 0.9%
Y-site only:
Hartmann’s
Y-site only and enalaprilat 0.625 mg/mL or weaker:
Potassium chloride 20 mmol/L
Additional information
Observe closely for anaphylactic reactions.
Use with caution in neonate; contains benzyl alcohol which has been linked to ‘gasping syndrome'.
Discard any unused vial contents.
Potentially hazardous medication: may require special handling precautions, refer to RCH Hazardous Medicines Policy or relevant local guideline.